Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Cardiology

368,060 Journal Article Views | Journal Analytics

Nanoparticles as contrast agents for MRI of atherosclerotic lesions

Submit a Paper



Publication Date: 22 Apr 2008

Journal: Clinical Medicine Insights: Cardiology

Citation: Clinical Medicine: Cardiology 2008:2 173-179

Abstract

Nanoparticle contrast agents for MRI may aid in identifying atherosclerotic lesions that give rise to ischemic events by means of penetration and retention in the plaque. These imaging agents may provide valuable information regarding plaque characteristics which can help determine the risk of plaque rupture. By increasing molecular flexibility or adding a means of specifically targeting ligands via antibody or peptide, nanoparticles can enhance certain regions of the atherosclerotic plaque. The development of single contrast agents detectable with multiple imaging modalities may further improve our ability to detect and characterize atherosclerosis in clinical and preclinical applications. These exciting developments may help in the realization of MRI as a powerful tool in the prevention of cardiovascular morbidity and mortality.


Downloads

PDF  (1.42 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Clinical Medicine Insights: Cardiology
I am impressed by the efficiency at each step of submission in the journal. Based on the first-hand experience, I am confident that this journal will have a great future, and the impact factor will rise rapidly.
Dr Jia Li (Alberta Health Services, Canada)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results